首页> Clinical cancer research : an official journal of the American Association for Cancer Research> A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma.

A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma.

导出 OA

翻译打印收藏纠错

第一作者： Jacob P,Laubach

第一单位： Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.

作者： Jacob P,Laubach ^[1] ; Chia-Jen,Liu ^[2] ; Noopur S,Raje ^[3] ; Andrew J,Yee ^[3] ; Philippe,Armand ^[1] ; Robert L,Schlossman ^[1] ; Jacalyn,Rosenblatt ^[4] ; Jacquelyn,Hedlund ^[5] ; Michael,Martin ^[6] ; Craig,Reynolds ^[7] ; Kenneth H,Shain ^[8] ; Ira,Zackon ^[9] ; Laura,Stampleman ^[10] ; Patrick,Henrick ^[1] ; Bradley,Rivotto ^[2] ; Kalvis T V,Hornburg ^[2] ; Henry J,Dumke ^[2] ; Stacey,Chuma ^[1] ; Alexandra,Savell ^[1] ; Damian R,Handisides ^[11] ; Stew,Kroll ^[11] ; Kenneth C,Anderson ^[1] ; Paul G,Richardson ^[12] ; Irene M,Ghobrial ^[12]

作者单位： Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.;Blood Cancer Research Partnership (BCRP), Boston, Massachusetts. ^[1] Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. ^[2] Massachusetts General Hospital, Boston, Massachusetts. ^[3] Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.;Beth Israel Deaconess Medical Center, Boston, Massachusetts. ^[4] Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.;Maine Center For Cancer Medicine, Scarborough, Maine. ^[5] Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.;The West Clinic, Memphis, Tennessee. ^[6] Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.;Ocala Oncology Center, Ocala, Florida. ^[7] Moffitt Cancer Center, Tampa, Florida. ^[8] Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.;New York Oncology Hematology, Albany, New York. ^[9] Blood Cancer Research Partnership (BCRP), Boston, Massachusetts.;Pacific Cancer Care, Salinas, California. ^[10] Threshold Pharmaceuticals, South San Francisco, California. ^[11] Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. irene_ghobrial@dfci.harvard.edu paul_richardson@dfci.harvard.edu.;Blood Cancer Research Partnership (BCRP), Boston, Massachusetts. ^[12]